美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ligand Pharmaceuticals Incorporated

0.1400

0.0000

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：0.1400

開：0.1400

低：0.1400

收：0.1400

資料載入中...

總覽公司新聞公告

Ligand Pharmaceuticals Incorporated2025財年第一財季實現淨利潤-42.45百萬美元，同比減少149.28%

Ligand Pharmaceuticals Incorporated盤中異動大幅下挫5.00%報100.34美元

Ligand Pharmaceuticals Incorporated跌3.97% 股價跌破100美元大關

Ligand Pharmaceuticals Incorporated漲4.14% 股價突破100美元大關

Ligand Pharmaceuticals Incorporated盤中異動早盤股價大跌5.11%報94.49美元

Ligand Pharmaceuticals Incorporated盤中異動股價大跌5.12%

Ligand Pharmaceuticals Incorporated盤中異動急速下跌5.12%

Ligand Pharmaceuticals Incorporated2024財年實現淨利潤-4.03百萬美元，同比減少107.49%

Ligand Pharmaceuticals Incorporated盤中異動股價大跌5.06%報116.05美元

Ligand Pharmaceuticals Incorporated盤中異動急速上漲5.07%報121.54美元

Ligand Pharmaceuticals Incorporated盤中異動大幅上漲5.18%

Ligand Pharmaceuticals Incorporated盤中異動急速上漲5.22%

Ligand Pharmaceuticals Incorporated盤中異動快速上漲5.04%

Ligand Pharmaceuticals Incorporated盤中異動臨近午盤股價大跌5.05%

Ligand Pharmaceuticals Incorporated盤中異動急速下跌5.26%

Ligand Pharmaceuticals Incorporated盤中異動臨近收盤急速下跌5.21%

Ligand Pharmaceuticals Incorporated盤中異動大幅拉昇5.00%

Ligand Pharmaceuticals Incorporated盤中異動臨近收盤快速跳水5.24%

Ligand Pharmaceuticals Incorporated盤中異動急速上漲5.29%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LGNZZ/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LGNZZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGNZZ\",,,,,undefined,":{"symbol":"LGNZZ","market":"US","secType":"STK","nameCN":"Ligand Pharmaceuticals Incorporated","latestPrice":0.14,"timestamp":1747925220000,"preClose":0.14,"halted":0,"volume":0,"delay":15,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"05-22 10:47:00 EDT 延時","open":0.14,"high":0.14,"low":0.14,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1747944000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.14,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGNZZ\",,,,,undefined,":{"symbol":"LGNZZ","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.14,"amplitude":0,"preClose":0.14,"low":0.14,"week52Low":0.1,"pbRate":"--","week52High":0.196,"institutionHeld":0,"latestPrice":0.14,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":0.14,"prevYearClose":0.1325,"prevWeekClose":0.139,"prevMonthClose":0.13,"prevQuarterClose":0.14,"fiveDayClose":0.139,"twentyDayClose":0.13,"sixtyDayClose":0.1227},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGNZZ\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536584228","title":"Ligand Pharmaceuticals Incorporated2025財年第一財季實現淨利潤-42.45百萬美元，同比減少149.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584228","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536584228?lang=zh_tw&edition=fundamental","pubTime":"2025-05-18 00:00","pubTimestamp":1747497624,"startTime":"0","endTime":"0","summary":"5月18日，Ligand Pharmaceuticals Incorporated公布财报，公告显示公司2025财年第一财季净利润为-42.45百万美元，同比减少149.28%；其中营业收入为45.33百万美元，同比增加46.32%，每股基本收益为-2.21美元。从资产负债表来看，Ligand Pharmaceuticals Incorporated总负债1.10亿美元，其中短期债务883000.00美元，资产负债比为8.23，流动比率为0.06。机构评级：截至2025年5月18日，当前有8家机构对Ligand Pharmaceuticals Incorporated目标价做出预测，其中目标均价为143.88美元，其中最低目标价为135.00美元，最高目标价为157.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000125a4821d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000125a4821d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","LGNXZ","LGNZZ","LGNYZ","LGNDZ"],"gpt_icon":0},{"id":"2533137122","title":"Ligand Pharmaceuticals Incorporated盤中異動 大幅下挫5.00%報100.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533137122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533137122?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 21:58","pubTimestamp":1746712696,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时58分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速下挫5.00%。截至发稿，该股报100.34美元/股，成交量1.413万股，换手率0.07%，振幅6.03%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为3.15%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821582094f095a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821582094f095a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0566484027.USD","LGND","LGNDZ","LGNXZ","LU1559883803.SGD","LGNZZ","BK4139","LGNYZ"],"gpt_icon":0},{"id":"2526870597","title":"Ligand Pharmaceuticals Incorporated跌3.97% 股價跌破100美元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2526870597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526870597?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 23:13","pubTimestamp":1744298006,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日23时13分，Ligand Pharmaceuticals Incorporated股票出现异动，股价快速下跌3.97%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.49%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Pasithea Therapeutics Corp.、Pmgc Holdings Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3383.92%、2231.66%、313.59%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc.，振幅分别为81.65%、71.43%、70.97%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231327a6b6b9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231327a6b6b9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","LGNXZ","BK4139","LGNYZ","LU1559883803.SGD","LGNDZ","LGND","LGNZZ","BK4007"],"gpt_icon":0},{"id":"2526311483","title":"Ligand Pharmaceuticals Incorporated漲4.14% 股價突破100美元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2526311483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526311483?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 01:27","pubTimestamp":1744219621,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时27分，Ligand Pharmaceuticals Incorporated股票出现波动，股价大幅上涨4.14%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Phio Pharmaceuticals Corp.、Humacyte, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为7456.81%、2932.86%、226.55%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Moolec Science Sa C/Wts 、Hepion Pharmaceuticals, Inc.，振幅分别为138.61%、108.26%、80.93%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001270194d0f9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001270194d0f9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LGNXZ","LGND","BK4007","LGNDZ","LU1559883803.SGD","LGNZZ","BK4139","LU0566484027.USD"],"gpt_icon":0},{"id":"2525044684","title":"Ligand Pharmaceuticals Incorporated盤中異動 早盤股價大跌5.11%報94.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525044684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525044684?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:42","pubTimestamp":1744033330,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时42分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速跳水5.11%。截至发稿，该股报94.49美元/股，成交量1.7641万股，换手率0.09%，振幅1.96%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.95%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214211aa2c5f83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214211aa2c5f83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LGNDZ","LGNYZ","LU1559883803.SGD","LGNXZ","LU0566484027.USD","BK4139","BK4007","LGND"],"gpt_icon":0},{"id":"2524827268","title":"Ligand Pharmaceuticals Incorporated盤中異動 股價大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524827268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524827268?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 21:35","pubTimestamp":1743687339,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时35分，Ligand Pharmaceuticals Incorporated股票出现波动，股价大幅下挫5.12%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Protagenic Therapeutics, Inc.、Osr Holdings, Inc.、Context Therapeutics Inc.涨幅较大，Protagenic Therapeutics, Inc.、Genprex, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为1186.42%、324.76%、103.10%，振幅较大的相关个股有Protagenic Therapeutics, Inc.、Context Therapeutics Inc.、Alaunos Therapeutics, Inc.，振幅分别为52.42%、19.82%、18.50%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213539a44cbc1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213539a44cbc1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LGNXZ","LU1559883803.SGD","BK4007","LGNYZ","LGNDZ","LGND","BK4139","LU0566484027.USD"],"gpt_icon":0},{"id":"2518275372","title":"Ligand Pharmaceuticals Incorporated盤中異動 急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518275372?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 22:02","pubTimestamp":1741615340,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时02分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速下挫5.12%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为668.89%、329.35%、92.62%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220221abf30860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220221abf30860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LU1559883803.SGD","LGNDZ","LGNZZ","LU0566484027.USD","BK4007","LGNXZ","BK4139","LGND"],"gpt_icon":0},{"id":"2517145817","title":"Ligand Pharmaceuticals Incorporated2024財年實現淨利潤-4.03百萬美元，同比減少107.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517145817?lang=zh_tw&edition=fundamental","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日，Ligand Pharmaceuticals Incorporated公布财报，公告显示公司2024财年净利润为-4.03百万美元，同比减少107.49%；其中营业收入为1.67亿美元，同比增加27.48%，每股基本收益为-0.22美元。从资产负债表来看，Ligand Pharmaceuticals Incorporated总负债1.11亿美元，其中短期债务1.29百万美元，资产负债比为8.49，流动比率为0.09。机构评级：截至2025年3月8日，当前有7家机构对Ligand Pharmaceuticals Incorporated目标价做出预测，其中目标均价为144.86美元，其中最低目标价为125.00美元，最高目标价为160.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000045a2647e57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000045a2647e57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNDZ","LGNXZ","LGNZZ","LGND","LGNYZ"],"gpt_icon":0},{"id":"2516630569","title":"Ligand Pharmaceuticals Incorporated盤中異動 股價大跌5.06%報116.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516630569?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:15","pubTimestamp":1741014937,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时15分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速下挫5.06%。截至发稿，该股报116.05美元/股，成交量1.4762万股，换手率0.08%，振幅4.65%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.09%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032315379637b830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032315379637b830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","LU0566484027.USD","LGNDZ","LGNXZ","BK4139","BK4007","LGNZZ","LU1559883803.SGD","LGNYZ"],"gpt_icon":0},{"id":"2516372598","title":"Ligand Pharmaceuticals Incorporated盤中異動 急速上漲5.07%報121.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516372598?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 01:07","pubTimestamp":1740762443,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时07分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅拉升5.07%。截至发稿，该股报121.54美元/股，成交量3.4864万股，换手率0.18%，振幅4.47%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.47%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010723a2582793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010723a2582793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LGNXZ","LGNYZ","LGNDZ","BK4139","LGND","BK4007","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2514810543","title":"Ligand Pharmaceuticals Incorporated盤中異動 大幅上漲5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514810543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514810543?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:23","pubTimestamp":1740669808,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时23分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速拉升5.18%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Quoin Pharmaceuticals Ltd、Alpha Tau Medical Ltd C/Wts 、Editas Medicine, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为885.78%、177.60%、104.84%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为74.16%、43.51%、34.80%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232328a256879a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232328a256879a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","LGND","LU0566484027.USD","LGNZZ","BK4007","LGNDZ","LGNYZ","LGNXZ","BK4139"],"gpt_icon":0},{"id":"2511110836","title":"Ligand Pharmaceuticals Incorporated盤中異動 急速上漲5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511110836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511110836?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 03:40","pubTimestamp":1739562048,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时40分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速上涨5.22%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3111.92%、792.89%、621.89%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150340489885ce50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150340489885ce50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","BK4007","LU1559883803.SGD","LU0566484027.USD","LGNXZ","BK4139","LGNDZ","LGNZZ","LGND"],"gpt_icon":0},{"id":"2505166784","title":"Ligand Pharmaceuticals Incorporated盤中異動 快速上漲5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505166784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505166784?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 05:01","pubTimestamp":1737493262,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日05时01分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅拉升5.04%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为1.82%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1799.35%、534.10%、193.14%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、69.14%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122050102abb39826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122050102abb39826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNDZ","BK4139","LGNXZ","LU0566484027.USD","LU1559883803.SGD","LGND","BK4007","LGNYZ","LGNZZ"],"gpt_icon":0},{"id":"2502289210","title":"Ligand Pharmaceuticals Incorporated盤中異動 臨近午盤股價大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502289210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502289210?lang=zh_tw&edition=fundamental","pubTime":"2025-01-11 00:56","pubTimestamp":1736528167,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时56分，Ligand Pharmaceuticals Incorporated股票出现异动，股价快速下挫5.05%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为1.75%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1213.88%、804.34%、226.94%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005608986206f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005608986206f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0566484027.USD","LGND","BK4007","LGNYZ","BK4139","LU1559883803.SGD","LGNDZ","LGNZZ","LGNXZ"],"gpt_icon":0},{"id":"2494335557","title":"Ligand Pharmaceuticals Incorporated盤中異動 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494335557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494335557?lang=zh_tw&edition=fundamental","pubTime":"2024-12-28 01:37","pubTimestamp":1735321061,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时37分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅跳水5.26%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Abpro Holdings, Inc、Vor Biopharma Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Neuphoria Therapeutics Inc.较为活跃，换手率分别为120.96%、59.02%、51.83%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Galectin Therapeutics Inc.、Abpro Holdings, Inc，振幅分别为147.50%、65.39%、62.45%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122801374295ef9a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122801374295ef9a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","BK4139","LGNZZ","BK4007","LGNYZ","LU0566484027.USD","LGNDZ","LU1559883803.SGD","LGNXZ"],"gpt_icon":0},{"id":"2492159462","title":"Ligand Pharmaceuticals Incorporated盤中異動 臨近收盤急速下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492159462?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 04:40","pubTimestamp":1734554447,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时40分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速跳水5.21%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.83%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3230.10%、678.34%、350.90%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、147.29%、105.17%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044047a1f95823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044047a1f95823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","LGNYZ","LGNXZ","LGNDZ","BK4007","LGNZZ","BK4139","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2491469200","title":"Ligand Pharmaceuticals Incorporated盤中異動 大幅拉昇5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491469200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491469200?lang=zh_tw&edition=fundamental","pubTime":"2024-12-16 22:50","pubTimestamp":1734360606,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时50分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速拉升5.00%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Viridian Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为43.41%、32.86%、30.98%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225006ab7c9d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225006ab7c9d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNXZ","LGNZZ","LGND","LU0566484027.USD","LGNDZ","BK4139","BK4007","LU1559883803.SGD","LGNYZ"],"gpt_icon":0},{"id":"2491512233","title":"Ligand Pharmaceuticals Incorporated盤中異動 臨近收盤快速跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491512233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491512233?lang=zh_tw&edition=fundamental","pubTime":"2024-12-13 04:43","pubTimestamp":1734036198,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时43分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速跳水5.24%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为1.65%。其相关个股中，Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为4327.26%、1267.12%、98.34%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304431895e9434d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304431895e9434d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNXZ","LGNZZ","LGND","LGNYZ","LGNDZ","LU1559883803.SGD","LU0566484027.USD","BK4139","BK4007"],"gpt_icon":0},{"id":"2485417845","title":"Ligand Pharmaceuticals Incorporated盤中異動 急速上漲5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485417845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485417845?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 01:00","pubTimestamp":1732208422,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时00分，Ligand Pharmaceuticals Incorporated股票出现异动，股价快速拉升5.29%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Briacell Therapeutics Corp.、Conduit Pharmaceuticals Inc.、Cidara Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为913.64%、496.34%、354.13%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010023971a7ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010023971a7ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","LU0566484027.USD","LGNXZ","LGNDZ","BK4139","LGNYZ","BK4007","LU1559883803.SGD","LGNZZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGNZZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"LGNZZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":null},{"date":"2024-08-06","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722974400000,"name":null,"time":"盤後","dateTimestamp":1722916800000,"actualEps":null},{"date":"2024-05-07","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715112000000,"name":null,"time":"盤後","dateTimestamp":1715054400000,"actualEps":null},{"date":"2022-11-07","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1667854800000,"name":null,"time":"盤後","dateTimestamp":1667797200000,"actualEps":null},{"date":"2022-08-08","symbol":"LGNZZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1659988800000,"name":null,"time":"盤後","dateTimestamp":1659931200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGNZZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGNZZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1744257600000}}}